CHD4

Chromodomain-helicase-DNA-binding protein 4 · Q14839 · CHD4 on Sugi Atlas →

667 patent compounds predicted against CHD4, 470 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Dinaciclib Dinaciclib (SCHEMBL12048446) 1.00 1/20
Dinaciclib Dinaciclib (SCHEMBL15637863) 1.00 1/20
Dinaciclib Dinaciclib (SCHEMBL23682977) 1.00 1/20
Dinaciclib Dinaciclib (SCHEMBL30176832) 1.00 1/20
SCHEMBL15576865 SCHEMBL15576865 0.86 1/20
SCHEMBL20366942 SCHEMBL20366942 0.84 1/20
SCHEMBL23815646 SCHEMBL23815646 0.84 1/20
SCHEMBL16366036 SCHEMBL16366036 0.84 1/20
SCHEMBL12048531 SCHEMBL12048531 0.83 1/20
SCHEMBL18738298 SCHEMBL18738298 0.82 1/20
SCHEMBL12953008 SCHEMBL12953008 0.81 1/20
SCHEMBL12953146 SCHEMBL12953146 0.81 1/20
SCHEMBL12953641 SCHEMBL12953641 0.81 1/20
SCHEMBL12954295 SCHEMBL12954295 0.81 1/20
SCHEMBL13116917 SCHEMBL13116917 0.81 1/20
SCHEMBL17898402 SCHEMBL17898402 0.80 1/20
SCHEMBL14346166 SCHEMBL14346166 0.79 1/20
SCHEMBL14346562 SCHEMBL14346562 0.78 1/20
SCHEMBL14364529 SCHEMBL14364529 0.78 1/20
SCHEMBL14276480 SCHEMBL14276480 0.77 1/20

Clinical trials — most relevant to CHD4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load PHASE1COMPLETED
Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma PHASE1UNKNOWN
Investigation of the HDAC4 Copy Number Variation and Its Effect on Gene and Protein Expression in Patients With ASD nanCOMPLETED
Global Profiling of Gene and Protein Expression Associated With Coronary Heart Disease Reversal nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
UTHealth Turner Syndrome Research Registry nanRECRUITING
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Research for Genetic Factors Involved in Congenital Dislocation of Hip: Genome-wide Association Study in Grand West France nanCOMPLETED
Genetics of Congenital Heart Disease nanRECRUITING
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions nanRECRUITING
DNA Methylation and Autoimmune Thyroid Diseases nanCOMPLETED
Accelerated Aging in Newborns and Adults With Congenital Heart Disease nanUNKNOWN
Clinical and Molecular Study of CHARGE Syndrom nanCOMPLETED
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia nanCOMPLETED
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study nanRECRUITING
Chromosomal Abnormalities in Patients With Congenital Heart Disease at Assiut University Children's Hospital nanNOT_YET_RECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Family Resilience Initiative Research Program nanUNKNOWN
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study nanNOT_YET_RECRUITING
CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma nanUNKNOWN
Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy nanNOT_YET_RECRUITING
Risk Burden of Lipoprotein Metabolic Gene Haplotypes nanCOMPLETED
Precision High-Intensity Training Through Epigenetics (PHITE) nanCOMPLETED
dbGaP Protocol: The Pediatric Cardiac Genetics Consortium (PCGC) nanCOMPLETED
Chromosome 18 Clinical Research Center nanRECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a CHD4 binder may also engage these)

ProteinNameSimilarity
Q6PDQ2 1.000 Q6PDQ2 →
A2A8L1 1.000 A2A8L1 →
Q8TDI0 1.000 Q8TDI0 →
D3ZD32 1.000 D3ZD32 →
CHD3 Chromodomain-helicase-DNA-binding protein 3 0.997 landscape →
D3ZA12 0.997 D3ZA12 →
A3KFM7 0.996 A3KFM7 →
Q8TD26 0.995 Q8TD26 →
O97159 0.993 O97159 →
Q9C813 0.992 Q9C813 →
Q03468 0.992 Q03468 →
DHX29 ATP-dependent RNA helicase DHX29 0.991 landscape →
Q9NEL2 0.991 Q9NEL2 →
Q22516 0.991 Q22516 →
B0R061 0.991 B0R061 →
B6ZLK2 0.991 B6ZLK2 →
E1B7X9 0.991 E1B7X9 →
Q96GQ7 0.991 Q96GQ7 →
KDM4B Lysine-specific demethylase 4B 0.991 landscape →
G5EBZ4 0.991 G5EBZ4 →
BRPF3 Bromodomain and PHD finger-containing protein 3 0.990 landscape →
Q04692 0.990 Q04692 →
Q8WML3 0.990 Q8WML3 →
Q9Y4B4 0.990 Q9Y4B4 →
A7A0P8 0.990 A7A0P8 →
Q6PGC1 0.990 Q6PGC1 →
E7EZF3 0.990 E7EZF3 →
Q7G8Y3 0.990 Q7G8Y3 →
Q27746 0.989 Q27746 →
Q6P158 0.989 Q6P158 →